To achieve our translational goals, we work in close collaboration with clinical research platforms. These collaborations provide shared access to a limited pool of patient samples and enable us to translate experimental findings into human biology through "proof-of-concept" studies using ex vivo cultures of human tissue biopsies.
Our main research base is the Steno Diabetes Center Aarhus (SDCA)—a leading translational research environment that integrates clinical care and research. SDCA promotes collaboration between clinicians, scientists, and patients, allowing real-world insights to inform cutting-edge research. This synergy accelerates the translation of discoveries into effective treatments and innovations for diabetes care. With state-of-the-art infrastructure and a strong interdisciplinary focus, SDCA ensures that scientific advancements rapidly benefit patients. Its commitment to education and global collaboration also makes it a key hub for knowledge exchange and a model of excellence in diabetes translational research.
In addition to our work at SDCA, we maintain clinical research collaborations with the Department of Clinical Immunology and Transfusion Medicine at Sahlgrenska University Hospital, as well as Viborg Regional Hospital.
Our main research base is the Steno Diabetes Center Aarhus (SDCA)—a leading translational research environment that integrates clinical care and research. SDCA promotes collaboration between clinicians, scientists, and patients, allowing real-world insights to inform cutting-edge research. This synergy accelerates the translation of discoveries into effective treatments and innovations for diabetes care. With state-of-the-art infrastructure and a strong interdisciplinary focus, SDCA ensures that scientific advancements rapidly benefit patients. Its commitment to education and global collaboration also makes it a key hub for knowledge exchange and a model of excellence in diabetes translational research.
In addition to our work at SDCA, we maintain clinical research collaborations with the Department of Clinical Immunology and Transfusion Medicine at Sahlgrenska University Hospital, as well as Viborg Regional Hospital.
"Proof-of-concept” studies are performed using ex vivo cultures of human tissue biopsies.
